Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Taylor

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Plos One|May 17, 2012
The gracilis myocutaneous free flap: a quantitative analysis of the fasciocutaneous blood supply and implications for autologous breast reconstructionIain S Whitaker, Maria Karavias, Ramin Shayan, et al.
BMC Evolutionary Biology|December 2, 2016
Plasticity in growth of farmed and wild Atlantic salmon: is the increased growth rate of farmed salmon caused by evolutionary adaptations to the commercial diet?Alison Catherine Harvey, Monica Favnebøe Solberg, Eva Troianou, et al.
Regulatory Toxicology and Pharmacology : RTP|September 10, 2021
Inter-laboratory performance of ICE histopathology scoring to identify UN GHS Category 1 surfactants and non-extreme pH detergentsChantra Eskes, Marcel V W Wijnands, Martina Hermann, et al.
Clinical & Experimental Metastasis|November 6, 2012
Tumor location and nature of lymphatic vessels are key determinants of cancer metastasisRamin Shayan, Rachael Inder, Tara Karnezis, et al.
Histopathology|June 28, 2012
Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasisRamin Shayan, Tara Karnezis, Rajmohan Murali, et al.
Retrovirology|April 25, 2016
HIV-1 capsid is involved in post-nuclear entry stepsNan-Yu Chen, Lihong Zhou, Paul J Gane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2006
Phase II study of sorafenib in patients with advanced hepatocellular carcinomaGhassan K Abou-Alfa, Lawrence Schwartz, Sergio Ricci, et al.
Molecular Cancer Therapeutics|July 5, 2012
Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor, inhibits proliferation of HER2-amplified breast cancer cell lines resistant to trastuzumab and lapatinibOndrej Kalous, Dylan Conklin, Amrita J Desai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Safety and efficacy of dacomitinib in korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: a phase I/II trialKeunchil Park, Byoung C Cho, Dong-Wan Kim, et al.
The Lancet. Oncology|December 3, 2014
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trialPasi A Jänne, Sai-Hong I Ou, Dong-Wan Kim, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Plos One|May 17, 2012
The gracilis myocutaneous free flap: a quantitative analysis of the fasciocutaneous blood supply and implications for autologous breast reconstructionIain S Whitaker, Maria Karavias, Ramin Shayan, et al.
BMC Evolutionary Biology|December 2, 2016
Plasticity in growth of farmed and wild Atlantic salmon: is the increased growth rate of farmed salmon caused by evolutionary adaptations to the commercial diet?Alison Catherine Harvey, Monica Favnebøe Solberg, Eva Troianou, et al.
Regulatory Toxicology and Pharmacology : RTP|September 10, 2021
Inter-laboratory performance of ICE histopathology scoring to identify UN GHS Category 1 surfactants and non-extreme pH detergentsChantra Eskes, Marcel V W Wijnands, Martina Hermann, et al.
Clinical & Experimental Metastasis|November 6, 2012
Tumor location and nature of lymphatic vessels are key determinants of cancer metastasisRamin Shayan, Rachael Inder, Tara Karnezis, et al.
Histopathology|June 28, 2012
Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasisRamin Shayan, Tara Karnezis, Rajmohan Murali, et al.
Retrovirology|April 25, 2016
HIV-1 capsid is involved in post-nuclear entry stepsNan-Yu Chen, Lihong Zhou, Paul J Gane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2006
Phase II study of sorafenib in patients with advanced hepatocellular carcinomaGhassan K Abou-Alfa, Lawrence Schwartz, Sergio Ricci, et al.
Molecular Cancer Therapeutics|July 5, 2012
Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor, inhibits proliferation of HER2-amplified breast cancer cell lines resistant to trastuzumab and lapatinibOndrej Kalous, Dylan Conklin, Amrita J Desai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Safety and efficacy of dacomitinib in korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: a phase I/II trialKeunchil Park, Byoung C Cho, Dong-Wan Kim, et al.
The Lancet. Oncology|December 3, 2014
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trialPasi A Jänne, Sai-Hong I Ou, Dong-Wan Kim, et al.
Pageof 14